Regulatory T-Cell Therapy for Graft-versus-host Disease.
about
HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effectImmunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.Advances in the Use of Regulatory T-Cells for the Prevention and Therapy of Graft-vs.-Host Disease.A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.
P2860
Regulatory T-Cell Therapy for Graft-versus-host Disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulatory T-Cell Therapy for Graft-versus-host Disease.
@en
Regulatory T-Cell Therapy for Graft-versus-host Disease.
@nl
type
label
Regulatory T-Cell Therapy for Graft-versus-host Disease.
@en
Regulatory T-Cell Therapy for Graft-versus-host Disease.
@nl
prefLabel
Regulatory T-Cell Therapy for Graft-versus-host Disease.
@en
Regulatory T-Cell Therapy for Graft-versus-host Disease.
@nl
P2093
P2860
P1476
Regulatory T-Cell Therapy for Graft-versus-host Disease.
@en
P2093
Anandharaman Veerapathran
Brain Betts
Claudio Anasetti
David Bastian
Jessica Heinrichs
P2860
P50
P577
2016-04-28T00:00:00Z